Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from Russell Microcap Value Index
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.48 USD | -1.99% | -8.64% | +0.68% |
May. 15 | Earnings Flash (SPRO) SPERO THERAPEUTICS Reports Q1 Revenue $9.3M | MT |
Mar. 13 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.68% | 81.38M | |
+9.64% | 114B | |
+12.90% | 107B | |
-4.97% | 22.22B | |
-0.82% | 21.28B | |
-4.64% | 18.8B | |
-6.02% | 17.51B | |
-39.36% | 17.17B | |
+6.36% | 14.14B | |
+34.16% | 12.2B |
- Stock Market
- Equities
- SPRO Stock
- News Spero Therapeutics, Inc.
- Spero Therapeutics, Inc.(NasdaqGS: SPRO) dropped from Russell Microcap Value Index